NCT02333448View on ClinicalTrials.gov

"Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis."

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

June 12, 2015

Primary Completion Date

September 17, 2019

Study Completion Date

September 17, 2019

Conditions
Invasive Candidiasis; Treatment With Echinocandin
Interventions
BIOLOGICAL

Blood sample taken on the day the treatment is initiated

BIOLOGICAL

Blood sample taken on day 3 after initiation of treatment

BIOLOGICAL

Blood sample taken on day 5 after initiation of

BIOLOGICAL

Blood sample taken on day 7 after initiation of treatment

BIOLOGICAL

Blood sample taken on day 10 after initiation of treatment

Trial Locations (1)

21000

CHU de DIJON, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02333448 - "Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis." | Biotech Hunter | Biotech Hunter